By Avraham Hermon, US Patent Agent, Israel Patent Attorney, Partner JMB Davis Ben-David

In May 2020, the United States Patent and Trademark Office (USPTO) initiated a program to allow for “prioritized examination” for patent applications having at least one claim to a product or process related to COVID-19.

Two months ago, I filed such an application for a client, which claimed priority to a PCT application that was filed before COVID-19 existed. Before entering national phase, the client told me that the invention also has practical utility in preventing the spread of COVID-19. Because obtaining a patent quickly is a strategic goal of the client, I suggested that rather than enter the national phase in the US ‘as normal’, he should file the US application as a continuation-in-part, claiming priority from the PCT application, and add the information and claims relating to the use of claimed product and process for preventing the spread of COVID-19. The client was happy to hear of this option, which allowed for prioritization of the examination of his application, without paying additional USPTO fees.

In the second week of January, a mere two months after filing, we received a phone call from the examiner who suggested that we perform an election of an invention group to be examined, which we did shortly thereafter. The examiner then issued an office action within a week.

In its normal course, this application would have taken about 1.5 years to begin examination, but that time was cut to two months due to the COVID-19-related program. This is just one more example of utilizing programs made available by the USPTO to successfully accelerate examination of patent applications.

More Posts You May Find Interesting